The Board has appointed Ms. Babita (DIN: 09064124) as a Non-Executive & Independent Director of the Company w.e.f 31st January, 2026 a brief profile pursuant to SEBI Circular dated CIR/CFD/CMD/4/2015 ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Johnson Pharmacare Ltd, at its meeting on 31st January 2026, appointed Ms. Babita (DIN: 09064124) as a Non-Executive & Independent Director with effect from the same date. The company confirmed she is not related to any existing directors or key managerial personnel and is not debarred by SEBI or any other authority. In the same meeting, the board accepted the resignation of Mr. Umesh Kumar (DIN: 07015921) as an Additional & Executive Director, also effective 31st January 2026. Mr. Umesh Kumar cited personal and unavoidable reasons for stepping down, and the company confirmed there are no other material reasons behind his exit. The filing is signed by Rajender Parsad, Additional Director.
This is a routine board reshuffle — an executive director departs for personal reasons while a new independent director comes on board. There is no indication of any governance red flag or operational impact, though shareholders may want to monitor whether further executive-level changes follow.